The effectiveness of adalimumab in the treatment of ulcerative colitis is under debate. Although controlled trials have shown that adalimumab is significantly better than placebo, the absolute clinical benefit is modest. We report data on the effectiveness of adalimumab in a cohort of ulcerative colitis patients treated in 22 Italian centres.
Gionchetti, P., Rizzello, F. (2013). Adalimumab in active ulcerative colitis: a "real-life" observational study. DIGESTIVE AND LIVER DISEASE, 45(9), 738-743 [10.1016/j.dld.2013.03.018].
Adalimumab in active ulcerative colitis: a "real-life" observational study.
GIONCHETTI, PAOLO;RIZZELLO, FERNANDO
2013
Abstract
The effectiveness of adalimumab in the treatment of ulcerative colitis is under debate. Although controlled trials have shown that adalimumab is significantly better than placebo, the absolute clinical benefit is modest. We report data on the effectiveness of adalimumab in a cohort of ulcerative colitis patients treated in 22 Italian centres.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
